Caisse DE Depot ET Placement DU Quebec Sells 156,383 Shares of Molina Healthcare, Inc. (NYSE:MOH)

Caisse DE Depot ET Placement DU Quebec reduced its position in Molina Healthcare, Inc. (NYSE:MOH - Free Report) by 63.4% during the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 90,281 shares of the company's stock after selling 156,383 shares during the period. Caisse DE Depot ET Placement DU Quebec owned approximately 0.16% of Molina Healthcare worth $26,276,000 at the end of the most recent quarter.

Several other hedge funds have also bought and sold shares of the business. Waldron Private Wealth LLC raised its holdings in shares of Molina Healthcare by 4.7% in the 4th quarter. Waldron Private Wealth LLC now owns 729 shares of the company's stock worth $212,000 after acquiring an additional 33 shares during the last quarter. Angeles Investment Advisors LLC boosted its holdings in Molina Healthcare by 5.4% during the 4th quarter. Angeles Investment Advisors LLC now owns 838 shares of the company's stock worth $244,000 after acquiring an additional 43 shares during the last quarter. Coldstream Capital Management Inc. lifted its position in shares of Molina Healthcare by 2.1% during the fourth quarter. Coldstream Capital Management Inc. now owns 2,346 shares of the company's stock valued at $683,000 after purchasing an additional 48 shares in the last quarter. Lindbrook Capital LLC boosted its holdings in Molina Healthcare by 38.5% during the fourth quarter. Lindbrook Capital LLC now owns 205 shares of the company's stock worth $60,000 after purchasing an additional 57 shares during the last quarter. Finally, Quadrant Capital Group LLC increased its stake in Molina Healthcare by 11.4% in the 4th quarter. Quadrant Capital Group LLC now owns 627 shares of the company's stock valued at $182,000 after buying an additional 64 shares during the last quarter. Institutional investors and hedge funds own 98.50% of the company's stock.

Wall Street Analyst Weigh In

Several research firms have weighed in on MOH. Sanford C. Bernstein began coverage on Molina Healthcare in a research report on Tuesday, April 22nd. They issued an "outperform" rating and a $414.00 price objective on the stock. Stephens reaffirmed an "equal weight" rating and issued a $345.00 price objective on shares of Molina Healthcare in a research report on Thursday, February 6th. Guggenheim began coverage on shares of Molina Healthcare in a report on Wednesday, April 9th. They issued a "neutral" rating on the stock. Wells Fargo & Company raised Molina Healthcare from an "equal weight" rating to an "overweight" rating and raised their target price for the stock from $295.00 to $372.00 in a research report on Wednesday, March 5th. Finally, Baird R W downgraded Molina Healthcare from a "strong-buy" rating to a "hold" rating in a research note on Tuesday, April 15th. Nine analysts have rated the stock with a hold rating and seven have given a buy rating to the company's stock. Based on data from MarketBeat, the company presently has an average rating of "Hold" and a consensus price target of $365.38.

Insider Transactions at Molina Healthcare

In other news, Director Steven J. Orlando sold 1,000 shares of the stock in a transaction that occurred on Monday, March 3rd. The stock was sold at an average price of $301.33, for a total value of $301,330.00. Following the sale, the director now directly owns 17,375 shares in the company, valued at approximately $5,235,608.75. This represents a 5.44 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, CEO Joseph M. Zubretsky sold 87,500 shares of the business's stock in a transaction on Wednesday, April 30th. The shares were sold at an average price of $320.06, for a total value of $28,005,250.00. Following the transaction, the chief executive officer now owns 257,715 shares of the company's stock, valued at approximately $82,484,262.90. The trade was a 25.35 % decrease in their position. The disclosure for this sale can be found here. In the last 90 days, insiders sold 89,169 shares of company stock worth $28,520,995. 1.10% of the stock is currently owned by company insiders.

Molina Healthcare Stock Performance

NYSE:MOH traded up $10.61 during trading hours on Wednesday, reaching $326.81. The company had a trading volume of 522,300 shares, compared to its average volume of 765,453. The company has a current ratio of 1.62, a quick ratio of 1.62 and a debt-to-equity ratio of 0.69. Molina Healthcare, Inc. has a 52 week low of $262.32 and a 52 week high of $365.23. The firm has a market cap of $17.71 billion, a price-to-earnings ratio of 16.00, a PEG ratio of 1.06 and a beta of 0.63. The firm's 50 day moving average price is $323.41 and its 200-day moving average price is $307.57.

Molina Healthcare (NYSE:MOH - Get Free Report) last announced its quarterly earnings data on Wednesday, April 23rd. The company reported $6.08 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $5.96 by $0.12. Molina Healthcare had a net margin of 2.90% and a return on equity of 28.13%. The firm had revenue of $11.15 billion during the quarter, compared to analysts' expectations of $10.86 billion. During the same period in the prior year, the company posted $5.73 earnings per share. The company's revenue for the quarter was up 12.2% compared to the same quarter last year. On average, analysts forecast that Molina Healthcare, Inc. will post 24.4 EPS for the current year.

Molina Healthcare Profile

Molina Healthcare, Inc provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces. It operates in four segments: Medicaid, Medicare, Marketplace, and Other. The company served in across 19 states. The company was founded in 1980 and is headquartered in Long Beach, California.